We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCNX
13026
Scienture Holdings
SCNX
$18.8M
$60K ﹤0.01%
+1,717
New +$95.2K
DXYN
13027
CALL
DELISTED
Dixie Group Inc
DXYN
$60K ﹤0.01%
10,400
-9,300
-47% -$50.6K
SPECW
13028
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$60K ﹤0.01%
+136,176
New +$65K
TCON
13029
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$60K ﹤0.01%
1,089
-734
-40% -$46.8K
HHLA.WS
13030
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$60K ﹤0.01%
107,425
+17
+0% +$9
OTMO
13031
PUT
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$60K ﹤0.01%
980
-107
-10% -$6.77K
IPVIW
13032
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$60K ﹤0.01%
75,000
CTIC
13033
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$60K ﹤0.01%
+24,300
New +$59.5K
ADTX
13034
DELISTED
ADITXT INC
ADTX
0
EQ icon
13035
Equillium
EQ
$150M
$59K ﹤0.01%
15,638
+4,729
+43% +$25.6K
OPTT icon
13036
Ocean Power Technologies
OPTT
$55.9M
$59K ﹤0.01%
39,947
+8,218
+26% +$16K
VVOS icon
13037
Vivos Therapeutics
VVOS
$4.77M
$59K ﹤0.01%
1,043
-2,122
-67% -$171K
WYY icon
13038
WidePoint Corp
WYY
$94.5M
$59K ﹤0.01%
+14,993
New +$71K
BTTX
13039
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$59K ﹤0.01%
+12,713
New +$104K
MARK
13040
PUT
DELISTED
Remark Holdings, Inc.
MARK
$59K ﹤0.01%
5,990
-1,990
-25% -$25.9K
HCIIW
13041
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$59K ﹤0.01%
88,003
-53,821
-38% -$46.9K
EMWP
13042
DELISTED
Eros Media World PLC
EMWP
$59K ﹤0.01%
12,207
+2,258
+23% +$25.8K
NAVB
13043
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$59K ﹤0.01%
58,562
+16,425
+39% +$23.1K
ACIU icon
13044
PUT
AC Immune
ACIU
$248M
$58K ﹤0.01%
11,800
-14,200
-55% -$82.5K
CNSP icon
13045
CNS Pharmaceuticals
CNSP
$8.07M
0
DERM icon
13046
Journey Medical
DERM
$190M
$58K ﹤0.01%
+10,761
New +$77.9K
EMX
13047
DELISTED
EMX Royalty
EMX
$58K ﹤0.01%
25,372
+11,131
+78% +$28.5K
LYRA
13048
DELISTED
LYRA THERAPEUTICS INC
LYRA
$58K ﹤0.01%
+265
New +$85.1K
OMEX icon
13049
Odyssey Marine Exploration
OMEX
$52.9M
$58K ﹤0.01%
+11,186
New +$67.8K
TTI icon
13050
CALL
TETRA Technologies
TTI
$1.27B
$58K ﹤0.01%
20,300
-30,000
-60% -$92.5K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.